chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Muscle pain; finger joints had Burning sensation/extreme joint pain in fingers and knees; Fingers so stiff can not bend them; Horrible back pain; Severe headache; legs felt weak and shaky; Injection site swollen; Injection site sore; Fatigue; feeling hot/knees were warm to touch; burning sensation; neck pain; super congestion; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscle pain), ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them), BACK PAIN (Horrible back pain) and HEADACHE (Severe headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for Hypertension, ASCORBIC ACID (VIT C), COLECALCIFEROL (VIT D3), ZINC, IRON, B-COMPLEX [CALCIUM PANTOTHENATE;CYANOCOBALAMIN;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE MONONITRATE] and MULTI VIT for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (Muscle pain), ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them), BACK PAIN (Horrible back pain), HEADACHE (Severe headache), MUSCULAR WEAKNESS (legs felt weak and shaky), INJECTION SITE SWELLING (Injection site swollen), INJECTION SITE PAIN (Injection site sore), FATIGUE (Fatigue), FEELING HOT (feeling hot/knees were warm to touch), BURNING SENSATION (burning sensation), NECK PAIN (neck pain) and NASAL CONGESTION (super congestion). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form and IBUPROFEN at a dose of UNK dosage form. On 08-Feb-2021, MYALGIA (Muscle pain), BACK PAIN (Horrible back pain), HEADACHE (Severe headache), MUSCULAR WEAKNESS (legs felt weak and shaky), INJECTION SITE SWELLING (Injection site swollen), INJECTION SITE PAIN (Injection site sore), FATIGUE (Fatigue), FEELING HOT (feeling hot/knees were warm to touch), NECK PAIN (neck pain) and NASAL CONGESTION (super congestion) had resolved. On 15-Feb-2021, ARTHRALGIA (finger joints had Burning sensation/extreme joint pain in fingers and knees), MUSCULOSKELETAL STIFFNESS (Fingers so stiff can not bend them) and BURNING SENSATION (burning sensation) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: additional information included email, medical history, patient information, concomitant medications  and significant events.
"Chest pressure", bilat. palms red, itchy swollen, left side of body "heavy and achy". Sx started at - 21:00 10-10-08 at - 16:00 10-11-08 went to an urgent care center.  Per Pt. Dr. told her it was an allergic reaction to the flu vaccine and gave her an injection of DIPHENHYDRAMINE.
Caller did not provide any additional AE details; HCP reports that VAQTA that expired on 03-DEC-2021, was accidentally administered to a patient today, 20-APR-2022.; This spontaneous report has been received from a medical assistant referring to a 22-month-old male patient. The patient's pertinent medical history, and previous drugs reactions or allergies.Concomitant medications and historical vaccines included diphtheria vaccine toxoid (+) hib vaccine conj (tet tox) (+) pertussis vaccine acellular 5-component (+) polio vaccine inact 3v (mrc 5) (+) tetanus vaccine toxoid (PENTACEL) and pneumococcal vaccine conj 7v (crm197) (PREVENAR).   On 20-APR-2022, the patient was accidentally vaccinated with an expired hepatitis a vaccine, inactivated (VAQTA) intramuscular injection,  at a dose of 0.5 milliliter for prophylaxis lot number T013204, expiration date: 03-DEC-2021 (route of administration  and anatomical location were not provided) . The reporter confirmed the product had been stored appropriately with no temperature excursions and did not provide any additional adverse event details(no adverse event).  The patient's mom was notified about the expired vaccine and a re-vaccination was offered, nonetheless, the patient's mom did not want another vaccination.
Information has been received from a registered nurse (RN) concerning a patient who was vaccinated with a dose of ZOSTAVAX that was stored at a freezer range above the recommended range.  The RN reported that the patient subsequently developed a shingles-like rash.  The patient was seen in a physician's office and the rash was cultured (results not provided).  No other symptoms or treatment was reported.  At the time of this report, the outcome was unknown.  This is one of several reports from the same source.  Additional information has been requested.
injection was done in a higher area and it hit the tendon; 3 inch red circle on the muscle where the injection was administered; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injection was done in a higher area and it hit the tendon) and VACCINATION SITE ERYTHEMA (3 inch red circle on the muscle where the injection was administered) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injection was done in a higher area and it hit the tendon) and VACCINATION SITE ERYTHEMA (3 inch red circle on the muscle where the injection was administered). At the time of the report, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injection was done in a higher area and it hit the tendon) and VACCINATION SITE ERYTHEMA (3 inch red circle on the muscle where the injection was administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Vaccine at 1pm on Friday. Woke up at 6am on Saturday with chest tightening every few minutes.  Felt like someone pushed on my chest every once in a while.  Seemed to subside throughout the day as I moved around.   Symptoms returned in the evening and Sunday morning I went to ER.  Dr. Performed EKG and said I now had Premature vascular contractions as shown on the EKG.  Said since it wasn't life threatening, he was not concerned about heart attack so suggested I call my primary care physician today (Monday 4/12).  I have tried to make an appointment with Dr. but so far they are not returning my call.
Pt. rec'd VARIVAX injection subcutaneously in left arm. When she returned to office area 3cm x 3 1/2cm red, blistering, hot to touch.
It started with mild irritation in my throat that made cough (dry cough). Then I started to have severe chills, body fatigue and coughing stopped. I now have fever (100.8) runny nose, my eyes hurt, still having body fatigue but less chills. I'm taking acetaminophen and Advil.
pt recvd vax; red rash both sides of face extending to neck; red eyes appeared on am on 10feb95; c/o itchy feeling at rash site;
After receiving the Johnson and Johnson I have muscle spasms in my left hand----they happen often during the day and at certain times. I never had them before I received the shot, only after being mandated for my job.
Case number PHEH2013US016819 is an initial spontaneous report from the nurse received on 05 Aug 2013. This report refers to a patient of an unknown age and gender. On an unknown date, the patient was accidentally vaccinated with only MenCYW-135 liquid component of MENVEO (batch number: not reported) and did not receive Men A lyophilized conjugate. No adverse event reported following this medication error. No other information was available.
This spontaneous report was received from a male patient of unknown age who was reporting on himself. The patient did not provide any information regarding concomitant medications, pertinent medical history, drug reactions or allergies. On 30-OCT-2017, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, route, lot # and expiration date were not provided) for prevention of pneumonia. On 31-OCT-2017, the patient experienced severe pain in the arm near the injection site. The patient did not seek medical attention. No treatment was given for the adverse event. The patient did not have a fever and reported that there was no swelling at the injection site. The outcome of adverse event was reported as not recovered. The relatedness between the adverse event and PNEUMOVAX 23 was not reported. No product quality complaint was reported.
Headache, fever: 101 degrees, chills, joint aches within 10 hours. Next day patient improved.
Suspected vaccination failure; Got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was known to the patient. The age at vaccination was not reported. The reporter stated that, he/she known the patient who got shingles after getting the Shingles vaccine.  The reporter said that, stop with the big pharma propaganda. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset for event and laboratory confirmation for shingles were not provided. This is 1 of the 3 linked cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR197941:Same reporter. Pt 2/3 US-GLAXOSMITHKLINE-US2021AMR197942:Same reporter. Pt 3/3
Fever at about 101, mild tachycardia, warm/body flush sensation, excess insomnia, body aches/headache throbbing, nausea sensations, and worsening TMJD-clenching even with my mouth guard on.  Went to the ER about 1230AM and received IV fluids, Tramadol and Zofran.
4/1 began having tingling in arms, hands, legs, feet.  Got worse and I called my doctor.  She prescribed potassium  and said make appt if not gone after I took pills.  By 4/5 tongue, nose, lips numb.  Experiencing electrical shock sensations in body and limbs jerking, leg kicking out -rt leg and shoulder jerking, left shoulder. By 4/6 no longer intermittent.  By 4/7 turned to painful pins and needles, hands became extremely tight and fingers and thumb contracted into palms.  Could not move fingers on both hands, no one could pull them out. They were locked in. 4/8 could not work because of hands.  4/9 Hands contracting intermittently. Contacted my doctor for appointment . Began having strange creepy-crawly feeling in scalp like bugs crawling all over me. Very intense sensation. 4/12 Called doctor again. Got appointment 4/13.  Saw doctor. They referred to neurologist.  4/16 Saw neurologist.  He said he had seen other patients w no history of nerve issues who had these same symptoms after first Covid shot.  He spike to colleague in Immunology and told me not to get second shot.  Took blood to check for antibodies. Sensations continue but are intermittent and most are improving slowly and less frequent. Lips, tongue and nose remain consistently tingling but other symptoms come and go and are decreased in pain since peak at about 16 days.
Patient developed redness and swelling and area is hot to touch on inside of the arm in which she received a pneumonia shot.  Area where shot was administered was not red or swollen.  I advised patient to ice the area, I drew a circle around the swollen area and told her to watch the area to make sure the swelling doesn't get larger.  I told her to take ibuprofen and a Benadryl tonight.  I will call her pcp tomorrow am and follow up with her after I speak to doctor.
SEVERE JOINT PAIN WITH MUSCLE CRAMPING, HEADACHE, NAUSEA, FEVER (99.6) 5 DAYS AFTER VACCINE ADMINISTERED
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On unknown dates the patient was vaccinated with the 1st and 2nd dose of the RECOMBIVAX HB, injection (strength, dose, route and lot # not reported). respectively. Subsequently, on an unknown date the patient received her 3rd dose of RECOMBIVAX HB, 6 months after the 2nd dose (inappropriate schedule of drug administered). No adverse events reported. Additional information has been requested.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 26-JAN-2017, the patient was vaccinated with an improperly stored dose of VARIVAX lot # M004328, expiration date 26-JAN-2018 (dose and route of administration were not provided) for prophylaxis. There were no adverse effects reported. Administered doses of VARIVAX were exposed to a temperature excursion of total time >-10°C but <8°C (>14°F but <46°F) for 10 hours. Data logger was involved.  There were previous excursions reported as follows: total time >-10°C but <8°C (>14°F but <46°F) for 22 hours and total time >-15°C but <-10°C (>5°F but <14°F) for 1 hour. This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1702USA007980: US-009507513-1703USA002299: US-009507513-1703USA002300.
Patient received second booster dose of the Moderna Covid-19 vaccine on 05-May-2022 lot number which was expired on 03-May-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received second booster dose of the Moderna Covid-19 vaccine on 05-May-2022 lot number which was expired on 03-May-2022) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 083J21A, 069H21A, 017C21A and 008B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received second booster dose of the Moderna Covid-19 vaccine on 05-May-2022 lot number which was expired on 03-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received second booster dose of the Moderna Covid-19 vaccine on 05-May-2022 lot number which was expired on 03-May-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. it was reported that patient had not experienced any side effects or adverse events after all the 4 doses of moderna Covid-19 vaccine. No treatment medications were reported.   This case was linked to MOD-2022-561462, MOD-2022-561458, MOD-2022-560262, MOD-2022-560259 (Patient Link).
the patient experienced no sympotms; improperly stored dose of Gadrasil 9 was administered to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported.  On 29-JAN-2020, the patient was vaccinated with improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, intramuscularly, lot # R016970, expiration date 22-MAR-2021 (exact dose and dose number were not reported) for prophylaxis.   The temperature excursion was 48.6 degrees Fahrenheit (F) for 73 hours 9 minutes. There were no previous excursions reported. The digital data logger was involved. The patient experienced no symptoms.
On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
I had my covid Vaccine on May 6th and June 3rd.  About 4 or 5 days after the first vaccine I had swelling under the opposite arm from where I had the shot.  The lymph glands were swollen, and a huge red patch appeared.  It looked like a burn.  The skin then peeled off and the arm was fine.   It happened again after the second shot about 3 days after.  Shot was in the left arm and the skin reaction was under the right arm again.  I tried Benadryl...didn't help.  I used hydrocortisone cream on the area, and the skin peeled off yesterday.
Abdominal pain lower right side; diarrhea; loss of appetite; spasms all unexplained; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (BNT162B2, solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in the right arm on 24Mar2021 12:00 as dose 2, single for COVID-19 immunization at pharmacy or drug Store. The patient medical history and concomitant medication was not reported. Patient previously took dose 1 of bnt162b2 via an unspecified route of administration, administered in arm right on 03mar2021 12:00 (lot number was not reported) as dose 1, single for COVID-19 immunization. No other vaccines were given within 4 weeks. No other medications were given within 2 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On an unspecified date of 2021 the patient experienced abdominal pain lower right side, diarrhoea, loss of appetite, spasms all unexplained. The patient underwent lab tests and procedures which included blood test resulted normal on an unknown date, computerised tomogram resulted normal on an unknown date, stool analysis resulted normal on an unknown date. Reporter stated that 3 other friends that had the vaccine at same time frame are experience similar complications. The clinical outcome of the events was reported as unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101098968 Same reporter/drug/event, different patient.
fever; chills; can feel the fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills) and PYREXIA (can feel the fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills) and PYREXIA (can feel the fever). At the time of the report, PYREXIA (fever), CHILLS (chills) and PYREXIA (can feel the fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Nov2021 as dose 3 (booster), single (Lot number: EW0217), in left arm and on 03Jun2022 as dose 4 (booster), single (Lot number: FP4554) at the age of 73 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 25Jul2022, outcome "not recovered" and all described as "Tested positive for Covid on 25Jul2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: I did another home Covid test. It was Positive; (unspecified date) Negative, notes: then finally had a negative test; (25Jul2022) Positive, notes: tested positive for Covid on 25Jul2022; (31Jul2022) Negative, notes: I tested negative on Sun 31Jul. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: Patient had two Pfizer Covid19 vaccines (03Mar2021 and 24Mar2021) and two Pfizer Covid19 boosters (dates listed on form, latest on 03Jun2022.) On 22Jul2022 I started w/ sore throat, added cough and runny nose on 23Jul2022, and tested positive for Covid on 25Jul2022. My PCP put me on Paxlovid. The metallic taste in mouth was very strong and constant until 29Jul2022 but I had a mild sore throat, congestion, with significant fatigue. I tested negative on Sun 31Jul and felt good with no symptoms. Ran some errands (masked.)On Mon. 01Aug the sore throat returned as well as some nasal congestion, so I did another home Covid test. It was Positive. I continued to be positive, with congestion and very, very tired until Sat. 06Aug, then finally had a negative test and felt good. Ran a bunch of errands (masked), then was fatigued. Today (Sun. 07Aug) continue w fatigue and sinus drain/slight sore throat, malaise, but still negative. Hooray! But when will this fatigue go away?? I am a normally very active 73-year-old. The patient has not taken Other medications in two weeks. The patient has no Known allergies and no other medical history. No follow-up attempts are possible. No further information is expected.
Information has been received from a medical assistant referring to a 17 months old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 24-JUN-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # K021151 with expiration date 02-NOV-2016; dose and route of administration were not reported)(Incorrect product storage). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.